Advanced Solid Tumours clinical trials

Explore recruiting advanced solid tumours clinical trials.

Recruiting advanced solid tumours studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Solid Tumours trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1 study to look at RP-6306 in combination with FOLFIRI as a treatment for Advanced Solid Tumours

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A clinical trial to look at how ZN-A-1041 alone or ZN-A-1041 plus some approved drugs works to reduce tumor size and how safe these drugs are at different doses.

France, Spain, Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD4360 in Adult Participants with Advanced Solid Tumours

Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A 2-part phase 1/2 open-label trial evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of ODM-212 in combination with anti-cancer therapy in participants with advanced solid tumours

Finland, Denmark, Spain, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 1b/2a Dose Escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Solid Tumours

Ireland, Spain, Germany, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A study to test how different doses of BI 1703880 in combination with ezabenlimab are tolerated in people with different types of advanced cancer (solid tumours)

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Advanced Solid Tumours trials by city

Advanced Solid Tumours in Toronto Advanced Solid Tumours in Vancouver Advanced Solid Tumours in Montreal Advanced Solid Tumours in Calgary Advanced Solid Tumours in Edmonton Advanced Solid Tumours in Ottawa Advanced Solid Tumours in Winnipeg Advanced Solid Tumours in Quebec City Advanced Solid Tumours in Hamilton Advanced Solid Tumours in Kitchener Advanced Solid Tumours in London Advanced Solid Tumours in Halifax Advanced Solid Tumours in New York Advanced Solid Tumours in Los Angeles Advanced Solid Tumours in Chicago Advanced Solid Tumours in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease